Position in TECH
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15,201,859
-$1,328,455 QoQ
Shares Held
290,889
+3.5% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. TECH ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in TECH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,201,859 | 290,889 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,530,314 | 281,080 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,753,920 | 301,167 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $15,158,250 | 294,621 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,616,790 | 300,474 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $18,809,121 | 261,129 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $20,923,675 | 261,775 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,497,541 | 272,122 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $21,054,986 | 299,119 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,973,232 | 297,735 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $20,297,112 | 298,180 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $28,361,282 | 347,437 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $25,513,495 | 343,894 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $26,555,912 | 320,414 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,539,136 | 78,016 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,567,441 | 75,784 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,028,561 | 74,160 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $9,493,965 | 73,406 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,714,022 | 71,932 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,012,626 | 115,601 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $11,294,911 | 118,293 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $9,591,200 | 120,815 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,713,011 | 124,539 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,976,663 | 135,974 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,005,217 | 126,679 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||